Health Care Industry
Industry: Email Alert RSS FeedPain Therapeutics Inc
MondayMorning, Dec 15, 2008
> Pain Therapeutics Inc. (Nasdaq) fell $1.96, or 24%, to $6.38 and King Pharmaceuticals Inc. (NYSE) slid 21 cents, or 2%, to $9.45 after FDA staff said they needed more data before approving Remoxy, one of the first painkillers designed to prevent abuse. The FDA "believes additional non-clinical data will be required to support the approval" of their experimental painkiller, the companies said in a statement.Most RecentHealth Care Articles
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Getting the global view: Nestle, led by Peter Brabeck-Letmathe, climbs to the #1 spot in this year's Best Companies for Leaders
Most Popular Business Publications
Content provided in partnership with
